A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient death in any care setting is a tragedy. In this case, it involves ibogaine, a medically complex intervention that sits outside regulated medical systems in the United States. On January 21, 2026, Ambio published a public statement reporting that a […]

The post Patient Safety After a Death: What Transparency Can and Cannot Do appeared first on Psychedelics Today.

Previous articleJanuary 2026 Psychedelic Bill Round-up
Next articleThe Psychedelic News Feed: January 26 – Febraury 1, 2026